A Phase 1 Blinded, Placebo-controlled Crossover Study to Evaluate the Effects of Oral TR 701 Free Acid on the Electrocardiogram.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2016
At a glance
- Drugs Tedizolid (Primary) ; Moxifloxacin
- Indications Bacterial infections
- Focus Therapeutic Use
- Sponsors Trius Therapeutics
- 29 Apr 2013 Results presented at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting, according to a Trius Therapeutics media release.
- 28 Apr 2013 Results presented at the 23rd European Congress of Clinical Microbiology and Infectious Diseases.
- 13 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.